-

AIS Healthcare Earns URAC Accreditation for Specialty Pharmacy

The designation continues to reflect AIS Healthcare’s commitment to advancing quality at its compounding pharmacies in Mississippi and Texas as well as Advanced Infusion Care locations in Georgia, Alabama, Mississippi, Florida, and Texas

DALLAS--(BUSINESS WIRE)--AIS Healthcare is proud to announce that its two state-of-the-art 503A compounding pharmacies (Ridgeland, Mississippi; Dallas, Texas) which produce patient-specific prescriptions for targeted drug delivery (TDD), and its five Advanced Infusion Care locations (Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; Dallas, Texas) have received the prestigious URAC accreditation for Specialty Pharmacy.

URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. By achieving re-accredited status, AIS Healthcare has demonstrated its commitment to going above and beyond to improve quality at every point along the care continuum.

“These accreditations are validation of what we do day in and day out—advancing quality,” said Michelle Wiest, Chief Operations Officer, AIS Healthcare. “It’s a prestigious recognition, and we’re proud to receive it for six of our leading pharmacies.”

AIS Healthcare is the leading targeted drug delivery and infusion care provider. In addition to compounding patient-specific prescriptions at its state-of-the-art 503A specialty pharmacies and providing personalized in-home infusion services, AIS Healthcare also offers a comprehensive suite of services to support both patients and providers.

“Throughout AIS Healthcare, we’re focused on doing more of what matters throughout the care continuum,” said Cindy Dumas, Vice President of Pharmacy Services and Pharmacist-in-Charge, Ridgeland. “This recognition from URAC shows how doing more to advance quality truly does result in meaningful improvements for patients and providers.”

AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers.

The URAC accreditations for Specialty Pharmacy are effective through November 1, 2025.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

About URAC

Founded in 1990, URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. URAC is a nonprofit organization using evidence-based measures and developing standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare. Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.

Contacts

Simon Castellanos
877.443.4006

AIS Healthcare


Release Versions

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

New Outpatient Infusion Center Opening in Marietta, GA Expands the National Presence of Advanced Infusion Care

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of another Advanced Infusion Care Center (AICC). This latest one is in Marietta, GA represents a significant step forward in AIC’s ongoing expansion and its commitment to increasing access to compassionate, high-quality infusion services across the country. The opening of more and more AICC sites highlights AIC’s strategi...

Advanced Infusion Care (AIC) Now Offers Kedrion Biopharma’s YIMMUGO® (Immune Globulin Intravenous Human-Dira, 10% Liquid)

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older. Approved by the U.S. Food and Drug Administration in June 2024, YIMMUGO® is now available at all AIC locations. The nationally accredited infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or in an infusion center set...

Advanced Infusion Care Expands National Footprint by Launching a New Outpatient Infusion Center in Phoenix, AZ

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of patient-specific infusion therapy, proudly announces the launch of Advanced Infusion Care Centers (AICC), with the opening of its first location in Phoenix, AZ. This new center marks a major milestone in AIC’s continued growth and its mission to expand access to compassionate, high quality infusion care nationwide. The creation of AICC reflects the company’s strategic commitment to meet...
Back to Newsroom